Evidence map›Paper›PMID 39960779›Full record

ArticleJournal of addiction medicine

Perinatal Substance Use-Related Content at Major Addiction Scientific Conferences: An Analysis of Oral Presentation Sessions.

Kevin Y Xu, Hendrée E Jones, Caitlin E Martin, Marcela C Smid, Max Jordan Nguemeni Tiako, Mishka Terplan, Elizabeth E Krans

Abstract read
In one paragraph

Article in Journal of addiction medicine. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Kevin Y XuHealth & Behavior Research Center, Division of Addiction Science, Prevention, and Treatment, Department of Psychiatry, Washington University School of Medicine, Saint Louis, MO (KYX); Department of Obstetrics and Gynecology, University of North Carolina School of Medicine, Chapel Hill, NC (HEJ); Department of Obstetrics and Gynecology, Virginia Commonwealth University School of Medicine, Richmond, VA (CEM); Department of Obstetrics and Gynecology, University of Utah School Health, Salt Lake City, UT (MCS); Department of Medicine, UCLA Geffen School of Medicine, Los Angeles, CA (MJNT); Friends Research Institute, Baltimore, MD (MT); and Department of Obstetrics, Gynecology, and Reproductive Sciences, University of Pittsburgh School of Medicine, Magee-Women's Research Institute, Pittsburgh, PA (EEK).ORCID 0000-0001-6595-695
Hendrée E Jones
Caitlin E Martin
Marcela C Smid
Max Jordan Nguemeni Tiako
Mishka Terplan
Elizabeth E Krans

Funding

Washington University Career Development Program in Drug Abuse and AddictionK12DA041449 · NIDA · WASHINGTON UNIVERSITY · PI Laura J. Bierut, Patricia A Cavazos-Rehg · 2017 to 2026
$4.2M
Using Big Data to Optimize Treatment of Opioid Use Disorder in PregnancyK08DA061258 · NIDA · WASHINGTON UNIVERSITY · PI Kevin Young Xu · 2024 to 2026
$664k
NIDA NIH HHS K08 DA061258NIDA NIH HHS K12 DA041449
6 · The paper itself

Abstract

backgroundSubstance use is a leading cause of pregnancy-associated death in the US. It is not known if the amount of perinatal content at national addiction science conferences reflects the research and education being done in this area nationally.

methodsWe analyzed oral presentation sessions at five major addiction scientific conferences from 2021 to 2023 (American Academy of Addiction Psychiatry [AAAP], American Society of Addiction Medicine [ASAM], Association for Multidisciplinary Education and Research in Substance use and Addiction [AMERSA], College on Problems of Drug Dependence [CPDD], Research Society on Alcohol [RSA]) closely affiliated with organizations involved with substance use-related research and funding. Conference programs were searched using an inductive framework to identify sessions focused on pregnancy or the postpartum period. Available session materials were reviewed, coded, and categorized into three mutually exclusive groups: 1) dedicated to the perinatal period, 2) containing some perinatal content, but were not dedicated to the perinatal period, and 3) sessions with no perinatal content.

resultsAcross >3,000 speakers, less than 10% of sessions (76/788) contained perinatal substance use-related content. Among these, 4.7% (39/788) sessions were dedicated to the perinatal period, with the common topic covered being epidemiologic data on long-term infant neurodevelopmental outcomes following in utero drug exposure (n = 22). An additional 37 had some perinatal content but were not primarily focused on perinatal substance use. Among sessions dedicated to the perinatal period, only two covered overdoses. DISCUSSION: Sessions dedicated to the perinatal period may not adequately reflect the diverse real-world needs of birthing people with substance use disorders. Whereas included sessions commonly covered neurodevelopmental outcomes (ie, fetal alcohol spectrum disorders), overdose and the postpartum period were seldom covered.

Indexed as

Addiction MedicineCongresses as TopicPregnancy ComplicationsSubstance-Related DisordersFemaleHumansPregnancycongresses as topicdrug overdosefemalegynecologyhealth inequitiesmeeting abstractobstetricsposterpregnancy

Identifiers

PMID39960779
PMCPMC12310381

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.